Retinal Diseases

Visual impairment and blindness have a profound and devastating impact on the people living with these conditions, their families and society as a whole. At Boehringer Ingelheim, we have expanded our global research and development activities to address eye diseases, specifically those affecting the back of the eye.

Science and innovation are at the core of the comprehensive pipeline portfolio we have built in Retinal Health, with the first assets already in clinical development.